drugset / Trial / NCT05950971

Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation

NCT05950971

Terminated 1 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Adult patients who are diagnosed new onset atrial fibrillation with rapid ventricular response within 7 days after non-cardiac non-thoracic surgery are enrolled.

Timeline

Start
2021-07-01
Primary completion
2022-01-21
Completion
2022-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule Intravenous
Subject Diltiazem Small molecule Intravenous
Subject Esmolol Other / unclassified Intravenous